Literature DB >> 7356067

GABA levels in CSF of patients with psychiatric disorders.

B I Gold, M B Bowers, R H Roth, D W Sweeney.   

Abstract

The authors measured gamma-aminobutyric acid (GABA) levels in the lumbar CSF of patients with depression, with psychosis, or undergoing evaluation for a neurologic disorder. GABA levels in the CSF from depressed patients were significantly decreased compared with neurologic control patients. CSF GABA levels in psychotic patients were not different from those in neurologic patients, although the data suggested a decrease in CSF GABA levels in patients with schizoaffective disorder.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356067     DOI: 10.1176/ajp.137.3.362

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  37 in total

1.  Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder?

Authors:  David T Plante; J Eric Jensen; Laura Schoerning; John W Winkelman
Journal:  Neuropsychopharmacology       Date:  2012-02-08       Impact factor: 7.853

Review 2.  Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments.

Authors:  Ronald S Duman; Gerard Sanacora; John H Krystal
Journal:  Neuron       Date:  2019-04-03       Impact factor: 17.173

3.  GABA-mediated modification of despair behavior in mice.

Authors:  K O Aley; S K Kulkarni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

4.  Changes in central GABAergic function following acute and repeated stress.

Authors:  M E Otero Losada
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

Review 5.  Glutamate, GABA, and CNS disease: a review.

Authors:  J E Walker
Journal:  Neurochem Res       Date:  1983-04       Impact factor: 3.996

6.  Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid.

Authors:  J John Mann; Maria A Oquendo; Kalycia Trishana Watson; Maura Boldrini; Kevin M Malone; Steven P Ellis; Gregory Sullivan; Thomas B Cooper; Shan Xie; Dianne Currier
Journal:  Depress Anxiety       Date:  2014-05-27       Impact factor: 6.505

Review 7.  Pharmacodynamic effects and possible therapeutic uses of THIP, a specific GABA-agonist.

Authors:  A V Christensen; O Svendsen; P Krogsgaard-Larsen
Journal:  Pharm Weekbl Sci       Date:  1982-10-22

Review 8.  Biological substrates underpinning diagnosis of major depression.

Authors:  Etienne Sibille; Beverly French
Journal:  Int J Neuropsychopharmacol       Date:  2013-05-14       Impact factor: 5.176

9.  Brain gamma-aminobutyrate transaminase and monoamine oxidase activities in suicide victims.

Authors:  F Sherif; J Marcusson; L Oreland
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

10.  Evidences for the involvement of monoaminergic and GABAergic systems in antidepressant-like activity of garlic extract in mice.

Authors:  Dinesh Dhingra; Vaibhav Kumar
Journal:  Indian J Pharmacol       Date:  2008-08       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.